February 2019

Optogenerapy > 2019 > February

Researchers from the Erasmus School of Health Policy & Management of the Erasmus University Rotterdam have done a systematic literature review using scientific databases to retrieve publications on the needs and preferences of relapsing-remitting multiple sclerosis patients when making treatment decisions. The publications analysed shed light on the patients’ needs and preferences regarding treatment decisions.   The literature review suggests that for multiple sclerosis patients the most important treatment characteristics...

Read More

In Optogenerapy project, light fuels the medical device, the energy to activate the engineered cells in the chamber for the production of IFN-ß protein, a therapeutic drug proven effective for the treatment of patients with Multiple Sclerosis.   In charge of the implant’s optical design, ASE Optics explains in this interview the importance of optics for channelling the light homogenously to all the cells in the membrane,...

Read More